Among our aging population, diseases like Alzheimer’s are approaching epidemic proportions — and by the time they’re detected, it’s often too late for treatment. UW Bioengineering Professor Valerie Daggett will share how her team is working on tests to detect these diseases years before symptoms develop — and how her lab is creating novel treatments to stop disease progression in its tracks. Come hear more about this revolutionary work.
Monday, April 1, 2024
5:30–6:30 p.m.
HUB North Ballroom or livestream on the lecture website
Free and open to the public. Closed-captioning and ASL interpretation provided.
Submit questions by email or text at questions@uw.edu or 206-616-8160.
This talk is intended for a general audience — and a recording will be available on the lecture website.
Upcoming Events in Community Talks and Outreach
-
UW Alzheimer's Research Update by Michael Rosenbloom, MD
Wednesday, September 25, 2024
at 2:00pm
Please join us for an afternoon presentation led by Dr. Rosenbloom about current research studies at the UW ADRC and how to become involved, hosted by the UW ADRC and Greenwood Senior Center.
-
Community Webinar: An Update on Lecanemab for Early Stage Alzheimer’s Disease
Thursday, September 26, 2024
at 12:00pm
Patients, families, and the wider community are invited to talk about the current amyloid-clearing infusion medications Leqembi (lecanemab) and Kisunla (donanemab) for the treatment of Alzheimer's. Come learn from our panel of experts which include, Dr. Thomas Grabowski, Dr. Michael Rosenbloom and clinical trials coordinator Darla Chapman, ARNP.
UW Alzheimer's Research Update by Michael Rosenbloom, MD
Wednesday, September 25, 2024 at 2:00pm
Please join us for an afternoon presentation led by Dr. Rosenbloom about current research studies at the UW ADRC and how to become involved, hosted by the UW ADRC and Greenwood Senior Center.
Community Webinar: An Update on Lecanemab for Early Stage Alzheimer’s Disease
Thursday, September 26, 2024 at 12:00pm
Patients, families, and the wider community are invited to talk about the current amyloid-clearing infusion medications Leqembi (lecanemab) and Kisunla (donanemab) for the treatment of Alzheimer's. Come learn from our panel of experts which include, Dr. Thomas Grabowski, Dr. Michael Rosenbloom and clinical trials coordinator Darla Chapman, ARNP.